Achieve Life Sciences, Inc. (ACHV) vs Attovia Therapeutics, Inc. (ATTO)
A side-by-side comparison of Achieve Life Sciences, Inc. and Attovia Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACHV
Achieve Life Sciences, Inc.
$7.11HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
ATTO
Attovia Therapeutics, Inc.
$17.87HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
Total return — ACHV vs ATTO
growth of $100 · dividends reinvested · last 1yACHV +13.5% (+13.5%/yr)ATTO -17.8% (-17.8%/yr)ACHV compounded faster over this window
ACHV ATTO
ACHV vs ATTO: by the numbers
- •ATTO is the larger company ($769M vs $729M market cap).
- •Both run net losses; ACHV's is the smaller (0.00% vs -4490.89% net margin).
Metrics side by side
Profitability
| Metric | ACHV | ATTO |
|---|---|---|
| Gross margin | 0.00% | 40.44% |
| Operating margin | 0.00% | -4974.74% |
| Net margin | 0.00% | -4490.89% |
| ROE | N/A | -40.21% |
| ROIC | N/A | -42.83% |
Growth (annualized)
| Metric | ACHV | ATTO |
|---|---|---|
| Total return CAGR (5Y) | -4.33% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.